![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Chromogenex | LSE:CGX | London | Ordinary Share | GB00B0B7XX32 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.325 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCGX RNS Number : 3325M Chromogenex PLC 27 January 2009 Chromogenex Plc ("Chromogenex" or "the Company) DEALINGS BY DIRECTOR Chromogenex, the developer and manufacturer of cosmetic and medical laser systems today announces that it was informed on Friday 23 January 2009, that Peter McGuinness transferred 24,340,000 ordinary shares in the Company to Michelle McGuinness, his wife, for nil consideration, on Friday 23 January 2009. The purpose of the transaction was to implement a long term tax planning strategy ("the Transfer"). Following the Transfer, Peter McGuinness has no direct interest in the share capital of the Company. He will be indirectly interested in the 24,340,000 ordinary shares in the Company held by his wife. This indirect holding amounts to 39.95% of the total issued share capital of the Company. For more information: Chromogenex PLC Tel: +44 20 8434 0540 Peter McGuinness, Chairman HB Corporate Imran Ahmad/Rory Creedon Tel: +44 (0)20 7510 8600 Threadneedle Communications Graham Herring/Alex White Tel: +44 (0) 20 7653 9850 This information is provided by RNS The company news service from the London Stock Exchange END RDSUBVVRKORAUAR
1 Year Chromogenex Chart |
1 Month Chromogenex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions